{"id":17510,"date":"2023-04-12T13:37:07","date_gmt":"2023-04-12T13:37:07","guid":{"rendered":"https:\/\/interhospi.com\/?p=17510"},"modified":"2023-04-12T13:37:07","modified_gmt":"2023-04-12T13:37:07","slug":"annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification","status":"publish","type":"post","link":"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/","title":{"rendered":"Annalise.ai Builds Momentum in U.S. Market with Seven Additional  FDA-Cleared Findings for Imaging Triage and Notification"},"content":{"rendered":"<div id='av_section_1'  class='avia-section main_color avia-section-default avia-no-border-styling  avia-bg-style-scroll  avia-builder-el-0  avia-builder-el-no-sibling   container_wrap fullsize' style=' '  ><div class='container' ><main  role=\"main\" itemprop=\"mainContentOfPage\"  class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-17510'><div class='entry-content-wrapper clearfix'>\n<div class=\"flex_column av_one_fifth  av-hide-on-mobile  flex_column_div av-zero-column-padding first  avia-builder-el-1  el_before_av_three_fifth  avia-builder-el-first  \" style='border-radius:0px; '><section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p style=\"text-align: center\"><\/p>\n<\/div><\/section><\/div><div class=\"flex_column av_three_fifth  flex_column_div av-zero-column-padding   avia-builder-el-3  el_after_av_one_fifth  el_before_av_one_fifth  \" style='border-radius:0px; '><section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p style=\"text-align: center\"><\/p>\n<\/div><\/section><br \/>\n<section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><header class=\"entry-content-header\"><h1 class=\"post-title entry-title\" itemprop=\"headline\">Annalise.ai Builds Momentum in U.S. Market with Seven Additional  FDA-Cleared Findings for Imaging Triage and Notification<\/h1><span class=\"post-meta-infos\">\/ <span class=\"blog-categories minor-meta\">in <a href=\"https:\/\/interhospi.com\/category\/e-news\/\" rel=\"tag\">E-News<\/a>  <\/span><\/span><\/header>\n<\/div><\/section><br \/>\n<section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><ul>\n<li>\n<h3>Annalise.ai has received new 510(k) FDA clearances for seven additional time-critical findings in its chest X-ray (CXR) and non-contrast head CT triage and notification portfolio.<\/h3>\n<\/li>\n<li>\n<h3>The latest 510(k) FDA clearances build on Annalise.ai\u2019s momentum for expanding into the U.S. market, bringing the total number of U.S.-available findings for its triage and notification products to nine<em>. <\/em><\/h3>\n<\/li>\n<\/ul>\n<p><strong>\u00a0<\/strong><\/p>\n<p><!--more--><\/p>\n<p>Annalise.ai, the global radiology AI company, announced that it has received FDA 510(k) clearances covering an additional seven findings as part of the company\u2019s innovative AI-assisted triage and notification (CADt) solutions. The clearances, including a suite of time-sensitive stroke findings and an expansion of findings for chest X-ray, build on Annalise\u2019s momentum and growth strategy in the U.S. market.<\/p>\n<p>Annalise Triage uses deep learning to identify the suspected presence of time-sensitive pathologies and flag priority cases within the radiology worklist, assisting the care team in treating patients with the most critical conditions first.<\/p>\n<\/div><\/section><br \/>\n<div  style='height:50px' class='hr hr-invisible   avia-builder-el-7  el_after_av_textblock  el_before_av_image '><span class='hr-inner ' ><span class='hr-inner-style'><\/span><\/span><\/div><br \/>\n<div  class='avia-image-container  av-styling-    avia-builder-el-8  el_after_av_hr  el_before_av_hr  avia-align-center '  itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\"  ><div class='avia-image-container-inner'><div class='avia-image-overlay-wrap'><img class='avia_image' src='https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2023\/04\/Naamloos.png' alt='' title='Naamloos' height=\"59\" width=\"335\"  itemprop=\"thumbnailUrl\"  \/><\/div><\/div><\/div><br \/>\n<div   class='hr hr-default   avia-builder-el-9  el_after_av_image  el_before_av_textblock '><span class='hr-inner ' ><span class='hr-inner-style'><\/span><\/span><\/div><br \/>\n<section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p>Although medical imaging in the U.S. declined during the pandemic, there has been a rapid bounce back in imaging volumes to higher-than pre-pandemic levels <sup>(1) <\/sup>amidst a shrinking radiology workforce and increasing rates of physician burnout.<\/p>\n<p>\u201cAI-assisted triage is becoming increasingly important in healthcare,\u201d said Rick Abramson, MD, MHCDS, FACR, Annalise.ai\u2019s Chief Medical Officer. \u201cTriage solutions drive quality improvement by enabling earlier detection and intervention for our most critically ill patients. And by prioritizing the radiology worklist, these solutions also help address some of the burnout issues that have affected our specialty since the pandemic.\u201d<\/p>\n<p>All FDA-cleared Annalise CXR and CT Brain findings are a subset of a comprehensive group of solutions, field-tested and available outside the U.S., with clinical studies showing improvements in detection\u00a0accuracy, diagnostic decision-making, and reporting speed.<\/p>\n<p><strong><em>Annalise Triage CT Brain<\/em><\/strong><\/p>\n<p>The latest 510(k) cleared findings for use in triage and notification (CADt) for CT Brain are:<\/p>\n<ul>\n<li>Acute subdural\/epidural hematoma<\/li>\n<li>Acute subarachnoid hemorrhage<\/li>\n<li>Intra-axial hemorrhage<\/li>\n<li>Intraventricular hemorrhage<\/li>\n<\/ul>\n<p>According to the American Stroke Association, cerebral hemorrhage accounts for approximately 13 percent of all strokes in the United States, with an estimated 41,000 cases occurring each year. <sup>(2)<\/sup> Triaging specific subtypes of brain hemorrhage is important because each type has its own specific causes, symptoms, and treatments.<\/p>\n<p>\u201cWe are thrilled to mark our entry into the U.S. neuroimaging space with this set of high-precision tools for prioritizing intracranial hemorrhage cases on non-contrast head CT,\u201d said Lakshmi Gudapakkam, CEO of Annalise.ai. \u201cAnnalise.ai is committed to developing the highest quality tools for advancing patient care and patient care efficiency in the U.S.\u201d<\/p>\n<p><strong><em>Annalise Triage Chest X-ray<\/em><\/strong><\/p>\n<p>Annalise.ai has also expanded its portfolio of FDA 510(k) cleared findings for CADt on CXR to a total of five, and now offers the highest number of findings for triage and notification on chest X-ray in the U.S. market. The findings now include:<\/p>\n<ul>\n<li>Pneumothorax<\/li>\n<li>Tension pneumothorax<\/li>\n<li>Pleural effusion<\/li>\n<li>Pneumoperitoneum<\/li>\n<li>Vertebral compression fracture<\/li>\n<\/ul>\n<p>As with head CT, quickly identifying imaging findings via CXR can help expedite diagnosis, guide treatment decisions, and improve patient outcomes.<\/p>\n<p>These findings continue the company\u2019s momentum in the U.S. which received its first FDA clearance in February of 2022 and now includes a total of nine FDA cleared findings. The first CADt FDA clearance was for the triage and notification of pneumothorax on chest X-ray and was the first product available in the U.S. market to differentiate a tension pneumothorax, allowing a clinical site to apply specific triaging rules for the most urgent tension pneumothorax cases.<\/p>\n<p><strong><em>About Annalise.ai<\/em><\/strong><\/p>\n<p>With accelerating advances in medical imaging technology, radiologists and other healthcare providers are now expected to diagnose patients quickly and accurately. Annalise.ai fuses the highest quality imaging data with the very best in computer science to produce comprehensive AI clinical decision support solutions, empowering clinicians to make accurate, faster decisions. Their patient-first approach is proudly clinician-led and comes from a deep understanding of the challenges faced in medical imaging. AI solutions provide clinicians with a second set of eyes, allowing them to detect and protect with confidence and drive better health outcomes for all patients.<\/p>\n<p>Annalise.ai is a joint venture between Australian healthcare technology company Harrison.ai and one of the world\u2019s largest radiology companies, I\u2013MED Radiology Network, a partnership that extends the capability of imaging analysis AI to deliver comprehensive modality solutions. The company is located in Australia, the United Kingdom, The Netherlands, and the United States.<\/p>\n<\/div><\/section><br \/>\n<div  class='av-social-sharing-box  avia-builder-el-11  el_after_av_textblock  avia-builder-el-last  av-social-sharing-box-minimal '><div class='av-share-box'><h5 class='av-share-link-description av-no-toc '>Share this<\/h5><ul class='av-share-box-list noLightbox'><li class='av-share-link av-social-link-facebook' ><a target=\"_blank\" aria-label=\"Share on Facebook\" href='https:\/\/www.facebook.com\/sharer.php?u=https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/&#038;t=Annalise.ai%20Builds%20Momentum%20in%20U.S.%20Market%20with%20Seven%20Additional%20%20FDA-Cleared%20Findings%20for%20Imaging%20Triage%20and%20Notification' aria-hidden='false' data-av_icon='\ue8f3' data-av_iconfont='entypo-fontello' title='' data-avia-related-tooltip='Share on Facebook' rel=\"noopener\"><span class='avia_hidden_link_text'>Share on Facebook<\/span><\/a><\/li><li class='av-share-link av-social-link-twitter' ><a target=\"_blank\" aria-label=\"Share on Twitter\" href='https:\/\/twitter.com\/share?text=Annalise.ai%20Builds%20Momentum%20in%20U.S.%20Market%20with%20Seven%20Additional%20%20FDA-Cleared%20Findings%20for%20Imaging%20Triage%20and%20Notification&#038;url=https:\/\/interhospi.com\/?p=17510' aria-hidden='false' data-av_icon='\ue8f1' data-av_iconfont='entypo-fontello' title='' data-avia-related-tooltip='Share on Twitter' rel=\"noopener\"><span class='avia_hidden_link_text'>Share on Twitter<\/span><\/a><\/li><li class='av-share-link av-social-link-whatsapp' ><a target=\"_blank\" aria-label=\"Share on WhatsApp\" href='https:\/\/api.whatsapp.com\/send?text=https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/' aria-hidden='false' data-av_icon='\uf232' data-av_iconfont='entypo-fontello' title='' data-avia-related-tooltip='Share on WhatsApp' rel=\"noopener\"><span class='avia_hidden_link_text'>Share on WhatsApp<\/span><\/a><\/li><li class='av-share-link av-social-link-linkedin' ><a target=\"_blank\" aria-label=\"Share on LinkedIn\" href='https:\/\/linkedin.com\/shareArticle?mini=true&#038;title=Annalise.ai%20Builds%20Momentum%20in%20U.S.%20Market%20with%20Seven%20Additional%20%20FDA-Cleared%20Findings%20for%20Imaging%20Triage%20and%20Notification&#038;url=https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/' aria-hidden='false' data-av_icon='\ue8fc' data-av_iconfont='entypo-fontello' title='' data-avia-related-tooltip='Share on LinkedIn' rel=\"noopener\"><span class='avia_hidden_link_text'>Share on LinkedIn<\/span><\/a><\/li><li class='av-share-link av-social-link-mail' ><a  aria-label=\"Share by Mail\" href='mailto:?subject=Annalise.ai%20Builds%20Momentum%20in%20U.S.%20Market%20with%20Seven%20Additional%20%20FDA-Cleared%20Findings%20for%20Imaging%20Triage%20and%20Notification&#038;body=https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/' aria-hidden='false' data-av_icon='\ue805' data-av_iconfont='entypo-fontello' title='' data-avia-related-tooltip='Share by Mail'><span class='avia_hidden_link_text'>Share by Mail<\/span><\/a><\/li><\/ul><\/div><\/div><\/p><\/div><div class=\"flex_column av_one_fifth  av-hide-on-mobile  flex_column_div av-zero-column-padding   avia-builder-el-12  el_after_av_three_fifth  avia-builder-el-last  \" style='border-radius:0px; '><section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p style=\"text-align: center\"><\/p>\n<\/div><\/section><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Annalise.ai has received new 510(k) FDA clearances for seven additional time-critical findings in its chest X-ray (CXR) and non-contrast head CT triage and notification portfolio. The latest 510(k) FDA clearances build on Annalise.ai\u2019s momentum for expanding into the U.S. market, bringing the total number of U.S.-available findings for its triage and notification products to nine. [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":17511,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-17510","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-e-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Annalise.ai Builds Momentum in U.S. Market with Seven Additional FDA-Cleared Findings for Imaging Triage and Notification - International Hospital<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Annalise.ai Builds Momentum in U.S. Market with Seven Additional FDA-Cleared Findings for Imaging Triage and Notification - International Hospital\" \/>\n<meta property=\"og:description\" content=\"Annalise.ai has received new 510(k) FDA clearances for seven additional time-critical findings in its chest X-ray (CXR) and non-contrast head CT triage and notification portfolio. The latest 510(k) FDA clearances build on Annalise.ai\u2019s momentum for expanding into the U.S. market, bringing the total number of U.S.-available findings for its triage and notification products to nine. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/\" \/>\n<meta property=\"og:site_name\" content=\"International Hospital\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-12T13:37:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2023\/04\/Naamloos.png\" \/>\n\t<meta property=\"og:image:width\" content=\"335\" \/>\n\t<meta property=\"og:image:height\" content=\"59\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"panglobal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"panglobal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/\"},\"author\":{\"name\":\"panglobal\",\"@id\":\"https:\/\/interhospi.com\/#\/schema\/person\/4689adfa1bdc4ca8bd2efdb65d94fac1\"},\"headline\":\"Annalise.ai Builds Momentum in U.S. Market with Seven Additional FDA-Cleared Findings for Imaging Triage and Notification\",\"datePublished\":\"2023-04-12T13:37:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/\"},\"wordCount\":1447,\"publisher\":{\"@id\":\"https:\/\/interhospi.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2023\/04\/Naamloos.png\",\"articleSection\":[\"E-News\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/\",\"url\":\"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/\",\"name\":\"Annalise.ai Builds Momentum in U.S. Market with Seven Additional FDA-Cleared Findings for Imaging Triage and Notification - International Hospital\",\"isPartOf\":{\"@id\":\"https:\/\/interhospi.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2023\/04\/Naamloos.png\",\"datePublished\":\"2023-04-12T13:37:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/#primaryimage\",\"url\":\"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2023\/04\/Naamloos.png\",\"contentUrl\":\"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2023\/04\/Naamloos.png\",\"width\":335,\"height\":59},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/interhospi.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Annalise.ai Builds Momentum in U.S. Market with Seven Additional FDA-Cleared Findings for Imaging Triage and Notification\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/interhospi.com\/#website\",\"url\":\"https:\/\/interhospi.com\/\",\"name\":\"International Hospital\",\"description\":\"The medical device information portal connecting healthcare professionals to global vendors\",\"publisher\":{\"@id\":\"https:\/\/interhospi.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/interhospi.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/interhospi.com\/#organization\",\"name\":\"International Hospital\",\"url\":\"https:\/\/interhospi.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/interhospi.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/01\/IH-logo.jpg\",\"contentUrl\":\"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/01\/IH-logo.jpg\",\"width\":652,\"height\":188,\"caption\":\"International Hospital\"},\"image\":{\"@id\":\"https:\/\/interhospi.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/interhospi.com\/#\/schema\/person\/4689adfa1bdc4ca8bd2efdb65d94fac1\",\"name\":\"panglobal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/interhospi.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/44754a569744e74e7138c83d1888f5c0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/44754a569744e74e7138c83d1888f5c0?s=96&d=mm&r=g\",\"caption\":\"panglobal\"},\"url\":\"https:\/\/interhospi.com\/author\/panglobal\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Annalise.ai Builds Momentum in U.S. Market with Seven Additional FDA-Cleared Findings for Imaging Triage and Notification - International Hospital","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/","og_locale":"en_GB","og_type":"article","og_title":"Annalise.ai Builds Momentum in U.S. Market with Seven Additional FDA-Cleared Findings for Imaging Triage and Notification - International Hospital","og_description":"Annalise.ai has received new 510(k) FDA clearances for seven additional time-critical findings in its chest X-ray (CXR) and non-contrast head CT triage and notification portfolio. The latest 510(k) FDA clearances build on Annalise.ai\u2019s momentum for expanding into the U.S. market, bringing the total number of U.S.-available findings for its triage and notification products to nine. [&hellip;]","og_url":"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/","og_site_name":"International Hospital","article_published_time":"2023-04-12T13:37:07+00:00","og_image":[{"width":335,"height":59,"url":"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2023\/04\/Naamloos.png","type":"image\/png"}],"author":"panglobal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"panglobal","Estimated reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/#article","isPartOf":{"@id":"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/"},"author":{"name":"panglobal","@id":"https:\/\/interhospi.com\/#\/schema\/person\/4689adfa1bdc4ca8bd2efdb65d94fac1"},"headline":"Annalise.ai Builds Momentum in U.S. Market with Seven Additional FDA-Cleared Findings for Imaging Triage and Notification","datePublished":"2023-04-12T13:37:07+00:00","mainEntityOfPage":{"@id":"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/"},"wordCount":1447,"publisher":{"@id":"https:\/\/interhospi.com\/#organization"},"image":{"@id":"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/#primaryimage"},"thumbnailUrl":"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2023\/04\/Naamloos.png","articleSection":["E-News"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/","url":"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/","name":"Annalise.ai Builds Momentum in U.S. Market with Seven Additional FDA-Cleared Findings for Imaging Triage and Notification - International Hospital","isPartOf":{"@id":"https:\/\/interhospi.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/#primaryimage"},"image":{"@id":"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/#primaryimage"},"thumbnailUrl":"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2023\/04\/Naamloos.png","datePublished":"2023-04-12T13:37:07+00:00","breadcrumb":{"@id":"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/#primaryimage","url":"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2023\/04\/Naamloos.png","contentUrl":"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2023\/04\/Naamloos.png","width":335,"height":59},{"@type":"BreadcrumbList","@id":"https:\/\/interhospi.com\/annalise-ai-builds-momentum-in-u-s-market-with-seven-additional-fda-cleared-findings-for-imaging-triage-and-notification\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/interhospi.com\/"},{"@type":"ListItem","position":2,"name":"Annalise.ai Builds Momentum in U.S. Market with Seven Additional FDA-Cleared Findings for Imaging Triage and Notification"}]},{"@type":"WebSite","@id":"https:\/\/interhospi.com\/#website","url":"https:\/\/interhospi.com\/","name":"International Hospital","description":"The medical device information portal connecting healthcare professionals to global vendors","publisher":{"@id":"https:\/\/interhospi.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/interhospi.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/interhospi.com\/#organization","name":"International Hospital","url":"https:\/\/interhospi.com\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/interhospi.com\/#\/schema\/logo\/image\/","url":"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/01\/IH-logo.jpg","contentUrl":"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/01\/IH-logo.jpg","width":652,"height":188,"caption":"International Hospital"},"image":{"@id":"https:\/\/interhospi.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/interhospi.com\/#\/schema\/person\/4689adfa1bdc4ca8bd2efdb65d94fac1","name":"panglobal","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/interhospi.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/44754a569744e74e7138c83d1888f5c0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/44754a569744e74e7138c83d1888f5c0?s=96&d=mm&r=g","caption":"panglobal"},"url":"https:\/\/interhospi.com\/author\/panglobal\/"}]}},"_links":{"self":[{"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/posts\/17510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/comments?post=17510"}],"version-history":[{"count":2,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/posts\/17510\/revisions"}],"predecessor-version":[{"id":17513,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/posts\/17510\/revisions\/17513"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/media\/17511"}],"wp:attachment":[{"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/media?parent=17510"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/categories?post=17510"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/tags?post=17510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}